| Data | Hora | Fonte | Título | Código | Companhia |
| 25/10/2019 | 17:16 | Edgar (US Regulatory) | Information Statement - All Other (definitive) (def 14c) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 25/10/2019 | 17:11 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 13/09/2019 | 17:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 13/09/2019 | 07:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 10/09/2019 | 07:03 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 30/08/2019 | 17:19 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 19/08/2019 | 18:06 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 14/08/2019 | 17:20 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 14/08/2019 | 17:13 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 11/06/2019 | 18:51 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 07/06/2019 | 10:20 | PR Newswire (Canada) | Edesa Biotech and Stellar Biotechnologies Complete Business Combination | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 08/05/2019 | 08:49 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 08/05/2019 | 08:45 | PR Newswire (US) | Stellar Biotechnologies Reports Second Quarter Financial Results | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 18/04/2019 | 18:09 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 29/03/2019 | 17:22 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (preliminary) (prem14a) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 08/03/2019 | 11:00 | PR Newswire (Canada) | Stellar Biotechnologies and Edesa Biotech Sign Share Exchange Agreement | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 08/02/2019 | 16:52 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 05/02/2019 | 19:20 | PR Newswire (US) | Stellar Biotechnologies Reports First Quarter Financial Results | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 06/12/2018 | 09:09 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 30/11/2018 | 19:34 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 30/11/2018 | 10:30 | PR Newswire (US) | Stellar Biotechnologies Reports Fiscal Year 2018 Financial Results | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 31/10/2018 | 08:30 | PR Newswire (US) | Stellar Biotechnologies to Present at BlueTech Summit | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 02/10/2018 | 17:48 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 05/09/2018 | 08:30 | PR Newswire (US) | Stellar Biotechnologies to Supply KLH to National Institutes of Health | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 28/08/2018 | 08:30 | PR Newswire (US) | Stellar Biotechnologies to Present at H. C. Wainwright Global Investment Conference | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 08/08/2018 | 08:45 | PR Newswire (US) | Stellar Biotechnologies Reports Third Quarter Financial Results | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 05/07/2018 | 08:30 | PR Newswire (US) | Stellar Issues Statement on Favorable Clinical Study Results | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 21/06/2018 | 08:30 | PR Newswire (US) | Stellar Reports Positive Research Results from KLH Glycosylation Study | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 18/06/2018 | 08:18 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |
| 06/06/2018 | 07:03 | Edgar (US Regulatory) | Securities Registration Statement (s-1) | NASDAQ:SBOT | Stellar Biotechnologies, Inc. (MM) |